Irene Hernández‐Martín
Pfizer (Spain)(ES)
Publications by Year
Research Areas
Food Allergy and Anaphylaxis Research, Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Pharmaceutical studies and practices, Asthma and respiratory diseases
Most-Cited Works
- → Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma(2020)385 cited
- → EAACI Biologicals Guidelines—Recommendations for severe asthma(2020)265 cited
- → Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population(2020)61 cited
- → Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain(2024)8 cited
- → Alergia a vegetales pertenecientes a la familia de las solanáceas(2019)5 cited
- → Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors(2025)3 cited
- → Patients with severe eosinophilic asthma treated with Mepolizumab: Results from our clinical practice(2019)1 cited
- → Alergia a antibióticos: perspectiva desde un hospital de tercer nivel(2018)
- → Efficacy of abrocitinib and dupilumab in itch‐dominant atopic dermatitis: An analysis of 2 trials(2026)
- → Allergy to antibiotics: Perspective from a tertiary care hospital(2019)